End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19,900 KRW | +0.15% | -0.30% | -7.87% |
06-03 | Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares. | CI |
06-03 | Samjin Pharmaceuticals Co., Ltd. authorizes a Buyback Plan. | CI |
Business Summary
Number of employees: 586
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products - Manufactured
85.8
%
| 239,759 | 87.5 % | 250,504 | 85.8 % | +4.48% |
Pharmaceutical Products - Merchandise
8.5
%
| - | - | 24,769 | 8.5 % | - |
Other
5.8
%
| 34,273 | 12.5 % | 16,856 | 5.8 % | -50.82% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
98.2
%
| 268,863 | 98.1 % | 286,741 | 98.2 % | +6.65% |
Overseas
1.8
%
| 5,169 | 1.9 % | 5,388 | 1.8 % | +4.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yong-Ju Choi
CEO | Chief Executive Officer | 67 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eui-Hwan Cho
CHM | Chairman | 82 | - |
Seung-Ju Choi
CHM | Chairman | 82 | - |
Yong-Ju Choi
CEO | Chief Executive Officer | 67 | - |
Wan-Gyun Hwang
BRD | Director/Board Member | 65 | 17-03-16 |
Sang-Bum Han
BRD | Director/Board Member | 57 | 19-03-21 |
Gi-Young Ko
BRD | Director/Board Member | 83 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,900,000 | 6,292,818 ( 45.27 %) | 1,125,036 ( 8.094 %) | 45.27 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
897,920 | 6.46% | 12,412,837 $ |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-7.87% | 184M | |
+20.76% | 43.77B | |
+28.00% | 22.83B | |
+20.25% | 15.56B | |
+18.82% | 14.34B | |
+55.83% | 12.96B | |
-0.05% | 6.79B | |
-12.70% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |
- Stock Market
- Equities
- A005500 Stock
- Company Samjin Pharmaceuticals Co., Ltd.